“…19 Evidence of anti-tumor activity was observed in 88.23% of patients. 19 Immune stimulation, 26 selective activation of programmed cellular death (apoptosis) in neoplastic cells, 27 and increased water content of tumor heterogeneities 28 were also documented. In addition, during the first interventional case of a patient with geographic atrophic age-related macular degeneration (AMD) associated with multi-infarct syndrome and severe ischemic disease, we observed amelioration of neurological symptoms, a confirmed single event of transitory color vision (not a hallucination), higher visual acuity, improved lens clarity, intraocular pressure decrease, electroretinogram (ERG) modifications and stable fluorescein angiography (FRG) 6 months post-IPLD treatment.…”